Substance use and regional gray matter volume in individuals at high risk of psychosis

European Neuropsychopharmacology

Volumn 22, Issue 2, 2012, Pages 114-122

  Stone, James M ^a,b   Bhattacharyya, Sagnik ^a   Barker, Gareth J ^a   McGuire, Philip K ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Alcohol; Cannabis; Gray matter; MRI; Nicotine; Psychosis; Tobacco

Indexed keywords

ALCOHOL; CANNABIS; NICOTINE;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BRAIN SIZE; CEREBELLUM; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GRAY MATTER; HUMAN; MALE; MENTAL HEALTH; MORPHOMETRICS; NEUROIMAGING; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PSYCHOSIS; SUBSTANCE ABUSE; TEMPORAL CORTEX;

ADULT; BRAIN; BRAIN MAPPING; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; REGRESSION ANALYSIS; RISK; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 84855187358     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2011.06.004     Document Type: Article

References (46)

1. Bangalore S.S., Prasad K.M., Montrose D.M., Goradia D.D., Diwadkar V.A., Keshavan M.S. Cannabis use and brain structural alterations in first episode schizophrenia-a region of interest, voxel based morphometric study. Schizophr. Res. 2008, 99(1-3):1-6.
2. Borgwardt S.J., Riecher-Rossler A., Dazzan P., Chitnis X., Aston J., Drewe M., Gschwandtner U., Haller S., Pfluger M., Rechsteiner E., D'Souza M., Stieglitz R.D., Radu E.W., McGuire P.K. Regional gray matter volume abnormalities in the at risk mental state. Biol. Psychiatry 2007, 61(10):1148-1156.
3. Brody A.L., Mandelkern M.A., Jarvik M.E., Lee G.S., Smith E.C., Huang J.C., Bota R.G., Bartzokis G., London E.D. Differences between smokers and nonsmokers in regional gray matter volumes and densities. Biol. Psychiatry 2004, 55(1):77-84.
4. Brugger S., Davis J.M., Leucht S., Stone J.M. Proton magnetic resonance spectroscopy and illness stage in schizophrenia-a systematic review and meta-analysis. Biol. Psychiatry 2010, 69(5):495-503.
5. Bullmore E.T., Suckling J., Overmeyer S., Rabe-Hesketh S., Taylor E., Brammer M.J. Global, voxel, and cluster tests, by theory and permutation, for a difference between two groups of structural MR images of the brain. IEEE Trans. Med. Imaging 1999, 18(1):32-42.
6. Cahn W., Hulshoff Pol H.E., Caspers E., van Haren N.E., Schnack H.G., Kahn R.S. Cannabis and brain morphology in recent-onset schizophrenia. Schizophr. Res. 2004, 67(2-3):305-307.
7. Cowan R.L., Joers J.M., Dietrich M.S. N-acetylaspartate (NAA) correlates inversely with cannabis use in a frontal language processing region of neocortex in MDMA (Ecstasy) polydrug users: a 3T magnetic resonance spectroscopy study. Pharmacol. Biochem. Behav. 2009, 92(1):105-110.
8. Demirakca T., Sartorius A., Ende G., Meyer N., Welzel H., Skopp G., Mann K., Hermann D. Diminished gray matter in the hippocampus of cannabis users: possible protective effects of cannabidiol. Drug Alcohol Depend. 2010, (May 20). doi:10.1111/j.1530-0277.2011.01514.x (Epub ahead of print).
9. Dickson J.M., Weavers H.M., Mitchell N., Winter E.M., Wilkinson I.D., Van Beek E.J., Wild J.M., Griffiths P.D. The effects of dehydration on brain volume-preliminary results. Int. J. Sports Med. 2005, 26(6):481-485.
10. Fusar-Poli P., Borgwardt S., Crescini A., Deste G., Kempton M.J., Lawrie S., Mc Guire P., Sacchetti E. Neuroanatomy of vulnerability to psychosis: a voxel-based meta-analysis. Neurosci. Biobehav. Rev. 2011, 35(5):1175-1185.
11. Gallinat J., Meisenzahl E., Jacobsen L.K., Kalus P., Bierbrauer J., Kienast T., Witthaus H., Leopold K., Seifert F., Schubert F., Staedtgen M. Smoking and structural brain deficits: a volumetric MR investigation. Eur. J. Neurosci. 2006, 24(6):1744-1750.
12. Gardini S., Cloninger C.R., Venneri A. Individual differences in personality traits reflect structural variance in specific brain regions. Brain Res. Bull. 2009, 79(5):265-270.
13. Gazdzinski S., Durazzo T.C., Studholme C., Song E., Banys P., Meyerhoff D.J. Quantitative brain MRI in alcohol dependence: preliminary evidence for effects of concurrent chronic cigarette smoking on regional brain volumes. Alcohol. Clin. Exp. Res. 2005, 29(8):1484-1495.
14. Hermann D., Sartorius A., Welzel H., Walter S., Skopp G., Ende G., Mann K. Dorsolateral prefrontal cortex N-acetylaspartate/total creatine (NAA/tCr) loss in male recreational cannabis users. Biol. Psychiatry 2007, 61(11):1281-1289.
15. Hill K., Mann L., Laws K.R., Stephenson C.M., Nimmo-Smith I., McKenna P.J. Hypofrontality in schizophrenia: a meta-analysis of functional imaging studies. Acta Psychiatr. Scand. 2004, 110(4):243-256.
16. Ho B.C., Andreasen N.C., Ziebell S., Pierson R., Magnotta V. Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. Arch. Gen. Psychiatry 2011, 68(2):128-137.
17. Ihaka R., Gentleman R. R: a language for data analysis and graphics. J. Comput. Graph. Stat. 1996, 5(3):299-314.
18. Kempton M.J., Ettinger U., Schmechtig A., Winter E.M., Smith L., McMorris T., Wilkinson I.D., Williams S.C., Smith M.S. Effects of acute dehydration on brain morphology in healthy humans. Hum. Brain Mapp. 2009, 30(1):291-298.
19. Lorenzetti V., Lubman D.I., Whittle S., Solowij N., Yucel M. Structural MRI findings in long-term cannabis users: what do we know?. Subst. Use Misuse 2010, 45(11):1787-1808.
20. Martin-Santos R., Fagundo A.B., Crippa J.A., Atakan Z., Bhattacharyya S., Allen P., Fusar-Poli P., Borgwardt S., Seal M., Busatto G.F., McGuire P. Neuroimaging in cannabis use: a systematic review of the literature. Psychol. Med. 2010, 40(3):383-398.
21. Mathalon D.H., Pfefferbaum A., Lim K.O., Rosenbloom M.J., Sullivan E.V. Compounded brain volume deficits in schizophrenia-alcoholism comorbidity. Arch. Gen. Psychiatry 2003, 60(3):245-252.
22. McClernon F.J. Neuroimaging of nicotine dependence: key findings and application to the study of smoking-mental illness comorbidity. J. Dual Diagn. 2009, 5(2):168-178.
23. Moffett J.R., Ross B., Arun P., Madhavarao C.N., Namboodiri A.M. N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology. Prog. Neurobiol. 2007, 81(2):89-131.
24. Moore G.J., Cortese B.M., Glitz D.A., Zajac-Benitez C., Quiroz J.A., Uhde T.W., Drevets W.C., Manji H.K. A longitudinal study of the effects of lithium treatment on prefrontal and subgenual prefrontal gray matter volume in treatment-responsive bipolar disorder patients. J. Clin. Psychiatry 2009, 70(5):699-705.
25. Navari S., Dazzan P. Do antipsychotic drugs affect brain structure? A systematic and critical review of MRI findings. Psychol. Med. 2009, 39(11):1763-1777.
26. Nesvag R., Frigessi A., Jonsson E.G., Agartz I. Effects of alcohol consumption and antipsychotic medication on brain morphology in schizophrenia. Schizophr. Res. 2007, 90(1-3):52-61.
27. Pantelis C., Velakoulis D., McGorry P.D., Wood S.J., Suckling J., Phillips L.J., Yung A.R., Bullmore E.T., Brewer W., Soulsby B., Desmond P., McGuire P.K. Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet 2003, 361(9354):281-288.
28. Phillips L.J., Yung A.R., McGorry P.D. Identification of young people at risk of psychosis: validation of Personal Assessment and Crisis Evaluation Clinic intake criteria. Aust. NZ J. Psychiatry 2000, 34:S164-S169. (Suppl.).
29. Rais M., Cahn W., Van Haren N., Schnack H., Caspers E., Hulshoff Pol H., Kahn R. Excessive brain volume loss over time in cannabis-using first-episode schizophrenia patients. Am. J. Psychiatry 2008, 165(4):490-496.
30. Rais M., Cahn W., Van Haren N., Schnack H., Caspers E., Hulshoff Pol H., Kahn R. Excessive brain volume loss over time in cannabis-using first-episode schizophrenia patients. Am. J. Psychiatry 2008, 165(4):490-496.
31. Rooney W.D., Lee J.H., Li X., Wang G.J., Franceschi D., Springer C.S., Volkow N.D. 4.0 T water proton T1 relaxation times in normal human brain and during acute ethanol intoxication. Alcohol. Clin. Exp. Res. 2000, 24(6):830-836.
32. Sasaki H., Abe O., Yamasue H., Fukuda R., Yamada H., Takei K., Suga M., Takao H., Kasai K., Aoki S., Ohtomo K. Structural and diffusional brain abnormality related to relatively low level alcohol consumption. NeuroImage 2009, 46(2):505-510.
33. Schroth G., Naegele T., Klose U., Mann K., Petersen D. Reversible brain shrinkage in abstinent alcoholics, measured by MRI. Neuroradiology 1988, 30(5):385-389.
34. Smieskova R., Fusar-Poli P., Allen P., Bendfeldt K., Stieglitz R.D., Drewe J., Radue E.W., McGuire P.K., Riecher-Rossler A., Borgwardt S.J. Neuroimaging predictors of transition to psychosis-a systematic review and meta-analysis. Neurosci. Biobehav. Rev. 2010, 34(8):1207-1222.
35. Smieskova R., Fusar-Poli P., Allen P., Bendfeldt K., Stieglitz R.D., Drewe J., Radue E.W., McGuire P.K., Riecher-Rossler A., Borgwardt S.J. The effects of antipsychotics on the brain: what have we learnt from structural imaging of schizophrenia?-A systematic review. Curr. Pharm. Des. 2009, 15(22):2535-2549.
36. Stone J.M., Day F., Tsagaraki H., Valli I., McLean M.A., Lythgoe D.J., O'Gorman R.L., Barker G.J., McGuire P.K. Glutamate dysfunction in people with prodromal symptoms of psychosis: relationship to gray matter volume. Biol. Psychiatry 2009, 66(6):533-539.
37. Sullivan E.V., Deshmukh A., Desmond J.E., Mathalon D.H., Rosenbloom M.J., Lim K.O., Pfefferbaum A. Contribution of alcohol abuse to cerebellar volume deficits in men with schizophrenia. Arch. Gen. Psychiatry 2000, 57(9):894-902.
38. Szeszko P.R., Robinson D.G., Sevy S., Kumra S., Rupp C.I., Betensky J.D., Lencz T., Ashtari M., Kane J.M., Malhotra A.K., Gunduz-Bruce H., Napolitano B., Bilder R.M. Anterior cingulate grey-matter deficits and cannabis use in first-episode schizophrenia. Br. J. Psychiatry 2007, 190:230-236.
39. Takahashi T., Wood S.J., Yung A.R., Soulsby B., McGorry P.D., Suzuki M., Kawasaki Y., Phillips L.J., Velakoulis D., Pantelis C. Progressive gray matter reduction of the superior temporal gyrus during transition to psychosis. Arch. Gen. Psychiatry 2009, 66(4):366-376.
40. Tregellas J.R., Shatti S., Tanabe J.L., Martin L.F., Gibson L., Wylie K., Rojas D.C. Gray matter volume differences and the effects of smoking on gray matter in schizophrenia. Schizophr. Res. 2007, 97(1-3):242-249.
41. Van Haren N.E., Koolschijn P.C., Cahn W., Schnack H.G., Hulshoff Pol H.E., Kahn R.S. Cigarette smoking and progressive brain volume loss in schizophrenia. Eur. Neuropsychopharmacol. 2010, 20(7):454-458.
42. Verbaten M.N. Chronic effects of low to moderate alcohol consumption on structural and functional properties of the brain: beneficial or not?. Hum. Psychopharmacol. 2009, 24(3):199-205.
43. Warner-Schmidt J.L., Duman R.S. Hippocampal neurogenesis: opposing effects of stress and antidepressant treatment. Hippocampus 2006, 16(3):239-249.
44. Welch K.A., McIntosh A.M., Job D.E., Whalley H.C., Moorhead T.W., Hall J., Owens D.G., Lawrie S.M., Johnstone E.C. The impact of substance use on brain structure in people at high risk of developing schizophrenia. Schizophr. Bull. 2010 Mar 11, (2010 Mar 11) (Epub ahead of print).
45. Yung A.R., Yuen H.P., McGorry P.D., Phillips L.J., Kelly D., Dell'Olio M., Francey S.M., Cosgrave E.M., Killackey E., Stanford C., Godfrey K., Buckby J. Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States. Aust. NZ J. Psychiatry 2005, 39(11-12):964-971.
46. Zipursky R.B., Lim K.C., Pfefferbaum A. MRI study of brain changes with short-term abstinence from alcohol. Alcohol. Clin. Exp. Res. 1989, 13(5):664-666.